Study on the Material Basis and Mechanisms of Achyrocline satureioides in the Treatment of Nonsmall Cell Lung Cancer Based on Network Pharmacology and Spatial Metabolomics
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.4c06682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Duo Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Academician Workstation, Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Metabolomics, Network Pharmacology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Central Level Major Increase and Decrease Expenditures Project, Workstation Project.
Abstract (Originalsprache)
Achyrocline satureioides have good therapeutic effects on nonsmall cell lung cancer (NSCLC). Nevertheless, it is still challenging to elucidate the active ingredients and mechanism of action due to their complex chemical composition. To address this, we innovatively combined network pharmacology with spatial metabolomics to comprehensively investigate the active components and the action mechanism in the present study. First, metabolomics of cells treated with the methanol extract of A. satureioides (ASM) utilizing high-resolution ultrahigh-performance liquid chromatography tandem mass spectrometry (HR-UHPLC-MS/MS) revealed 32 changed metabolites and 7 enriched metabolic pathways, confirming the anti-NSCLC effect of ASM and its impact on endogenous metabolites at the cellular level. Then, 69 chemical components in the ASM were identified using HR-UHPLC-MS/MS, followed by the screening of 6 core components and 10 core targets of anti-NSCLC with the help of network pharmacology and molecular docking. Lastly, quercetin, the most abundant compound among the six core active ingredients, was chosen for evaluating its anti-NSCLC effect and the potential mechanism using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). 51 altered endogenous metabolites were screened, and pathway enrichment analysis results were consistent with cell metabolomics, corroborating our network pharmacology predictions. In addition, we also observed the accumulation of three metabolites of quercetin in the tumor tissues. Network pharmacology combined with MSI elucidated the metabolic mechanisms by which A. satureioides treats NSCLC, offering new insights into herbal cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Academician Workstation, Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi, China.
- Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
ORCID-Profile: Jing Han, Huihui Liu, Zongxiu Nie
Förderung
- Central Level Major Increase and Decrease Expenditures Project
- Workstation Project
Zitieren
APA
Shen, D., Min, J., Chen, J., Yan, D., Han, J., Liu, H., Yu, X., Nie, Z., & Li, B. (2025). Study on the Material Basis and Mechanisms of Achyrocline satureioides in the Treatment of Nonsmall Cell Lung Cancer Based on Network Pharmacology and Spatial Metabolomics. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c06682
Vancouver
Shen D, Min J, Chen J, Yan D, Han J, Liu H, et al. Study on the Material Basis and Mechanisms of Achyrocline satureioides in the Treatment of Nonsmall Cell Lung Cancer Based on Network Pharmacology and Spatial Metabolomics. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.4c06682
BibTeX
@article{Shen2025,
author = {Shen, Duo and Min, Jianxin and Chen, Jie and Yan, Dongmei and Han, Jing and Liu, Huihui and Yu, Xi and Nie, Zongxiu and Li, Bin},
title = {Study on the Material Basis and Mechanisms of Achyrocline satureioides in the Treatment of Nonsmall Cell Lung Cancer Based on Network Pharmacology and Spatial Metabolomics},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.4c06682}
}
EUVIMED